| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Hoth Therapeutics, Inc. (HOTH) has 1 insider with recent SEC Form 4 filings, including 3 buys and 1 sell. HOTH is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 547.4K | $359.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | Knie Robb | CEO And President | Buy | 25,000 | $0.67 | $16,750.00 | +75.5% | +20.1% | +81.8% | |
| Sep 19, 2022 | Knie Robb | CEO And President | Buy | 10,000 | $0.39 | $3,900.00 | +1.2% | -69.4% | -82.8% | |
| Sep 16, 2022 | Knie Robb | CEO And President | Buy | 10,000 | $0.40 | $4,000.00 | +1.2% | -56.7% | -80.9% | |
| May 26, 2020 | Hayes Anthony46 | 10% Owner | Sell | 400,000 | $1.25 | $500,000.00 | -26.1% | - | - |